Expression, glycoform characterization, and antibody-binding of HIV-1 V3 glycopeptide domain fused with human IgG1-Fc

Bioconjugate Chemistry

Volumn 21, Issue 5, 2010, Pages 875-883

  Yang, Qiang ^a   Li, Cishan ^a   Wei, Yadong ^a   Huang, Wei ^a   Wang, Lai Xi ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; EPITOPE; GLYCOPEPTIDE; GLYCOPROTEIN GP 120; HUMAN IMMUNODEFICIENCY VIRUS 1 GLYCOPROTEIN 120; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; HYBRID PROTEIN; IMMUNOGLOBULIN FC FRAGMENT; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G1 ANTIBODY; MANNOSE; NEUTRALIZING ANTIBODY; UNCLASSIFIED DRUG;

ANTIBODY COMBINING SITE; ANTIGEN BINDING; ARTICLE; CELL STRAIN HEK293; CONTROLLED STUDY; EMBRYO; GLYCOSYLATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOGLOBULIN VARIABLE REGION; MUTATION; NONHUMAN; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; VIRUS ENTRY; VIRUS STRAIN;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 77952575336     PISSN: 10431802     EISSN: 15204812     Source Type: Journal    
DOI: 10.1021/bc9004238     Document Type: Article

References (35)

1. Burton, D. R., Desrosiers, R. C., Doms, R. W., Koff, W. C., Kwong, P. D., Moore, J. P., Nabel, G. J., Sodroski, J., Wilson, I. A., and Wyatt, R. T. (2004) HIV vaccine design and the neutralizing antibody problem Nat. Immunol. 5, 233-236
2. Zolla-Pazner, S. (2004) Identifying epitopes of HIV-1 that induce protective antibodies Nat. Rev. Immunol. 4, 199-210
3. Karlsson Hedestam, G. B., Fouchier, R. A., Phogat, S., Burton, D. R., Sodroski, J., and Wyatt, R. T. (2008) The challenges of eliciting neutralizing antibodies to HIV-1 and to influenza virus Nat. Rev. Microbiol. 6, 143-155
4. Ghiara, J. B., Stura, E. A., Stanfield, R. L., Profy, A. T., and Wilson, I. A. (1994) Crystal structure of the principal neutralization site of HIV-1 Science 264, 82-85
5. Huang, C. C., Tang, M., Zhang, M. Y., Majeed, S., Montabana, E., Stanfield, R. L., Dimitrov, D. S., Korber, B., Sodroski, J., Wilson, I. A., Wyatt, R., and Kwong, P. D. (2005) Structure of a V3-containing HIV-1 gp120 core Science 310, 1025-1028
6. Gorny, M. K., Conley, A. J., Karwowska, S., Buchbinder, A., Xu, J. Y., Emini, E. A., Koenig, S., and Zolla-Pazner, S. (1992) Neutralization of diverse human immunodeficiency virus type 1 variants by an anti-V3 human monoclonal antibody J. Virol. 66, 7538-7542
7. Gorny, M. K., Williams, C., Volsky, B., Revesz, K., Cohen, S., Polonis, V. R., Honnen, W. J., Kayman, S. C., Krachmarov, C., Pinter, A., and Zolla-Pazner, S. (2002) Human monoclonal antibodies specific for conformation-sensitive epitopes of V3 neutralize human immunodeficiency virus type 1 primary isolates from various clades J. Virol. 76, 9035-9045
8. Zolla-Pazner, S., Zhong, P., Revesz, K., Volsky, B., Williams, C., Nyambi, P., and Gorny, M. K. (2004) The cross-clade neutralizing activity of a human monoclonal antibody is determined by the GPGR V3 motif of HIV type 1 AIDS Res. Hum. Retroviruses 20, 1254-1258
9. Rizzuto, C. D., Wyatt, R., Hernandez-Ramos, N., Sun, Y., Kwong, P. D., Hendrickson, W. A., and Sodroski, J. (1998) A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding Science 280, 1949-1953
10. Hoffman, T. L. and Doms, R. W. (1999) HIV-1 envelope determinants for cell tropism and chemokine receptor use Mol. Membr. Biol. 16, 57-65
11. Rizzuto, C. and Sodroski, J. (2000) Fine definition of a conserved CCR5-binding region on the human immunodeficiency virus type 1 glycoprotein 120 AIDS Res. Hum. Retroviruses 16, 741-749
12. Basmaciogullari, S., Babcock, G. J., Van Ryk, D., Wojtowicz, W., and Sodroski, J. (2002) Identification of conserved and variable structures in the human immunodeficiency virus gp120 glycoprotein of importance for CXCR4 binding J. Virol. 76, 10791-10800
13. Hartley, O., Klasse, P. J., Sattentau, Q. J., and Moore, J. P. (2005) V3: HIVs switch-hitter AIDS Res. Hum. Retroviruses 21, 171-189
14. Leonard, C. K., Spellman, M. W., Riddle, L., Harris, R. J., Thomas, J. N., and Gregory, T. J. (1990) Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells J. Biol. Chem. 265, 10373-10382
15. Zhu, X., Borchers, C., Bienstock, R. J., and Tomer, K. B. (2000) Mass spectrometric characterization of the glycosylation pattern of HIV-gp120 expressed in CHO cells Biochemistry 39, 11194-11204
16. Sanders, R. W., Venturi, M., Schiffner, L., Kalyanaraman, R., Katinger, H., Lloyd, K. O., Kwong, P. D., and Moore, J. P. (2002) The mannose-dependent epitope for neutralizing antibody 2G12 on human immunodeficiency virus type 1 glycoprotein gp120 J. Virol. 76, 7293-7305
17. Scanlan, C. N., Pantophlet, R., Wormald, M. R., Ollmann Saphire, E., Stanfield, R., Wilson, I. A., Katinger, H., Dwek, R. A., Rudd, P. M., and Burton, D. R. (2002) The broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2G12 recognizes a cluster of alpha1-2 mannose residues on the outer face of gp120 J. Virol. 76, 7306-7321
18. Calarese, D. A., Scanlan, C. N., Zwick, M. B., Deechongkit, S., Mimura, Y., Kunert, R., Zhu, P., Wormald, M. R., Stanfield, R. L., Roux, K. H., Kelly, J. W., Rudd, P. M., Dwek, R. A., Katinger, H., Burton, D. R., and Wilson, I. A. (2003) Antibody domain exchange is an immunological solution to carbohydrate cluster recognition Science 300, 2065-2071
19. Calarese, D. A., Lee, H. K., Huang, C. Y., Best, M. D., Astronomo, R. D., Stanfield, R. L., Katinger, H., Burton, D. R., Wong, C. H., and Wilson, I. A. (2005) Dissection of the carbohydrate specificity of the broadly neutralizing anti-HIV-1 antibody 2G12 Proc. Natl. Acad. Sci. U.S.A. 102, 13372-13377
20. Sharon, M., Gorlach, M., Levy, R., Hayek, Y., and Anglister, J. (2002) Expression, purification, and isotope labeling of a gp120 V3 peptide and production of a Fab from a HIV-1 neutralizing antibody for NMR studies Protein Expression Purif. 24, 374-383
21. Gorny, M. K., Revesz, K., Williams, C., Volsky, B., Louder, M. K., Anyangwe, C. A., Krachmarov, C., Kayman, S. C., Pinter, A., Nadas, A., Nyambi, P. N., Mascola, J. R., and Zolla-Pazner, S. (2004) The V3 loop is accessible on the surface of most human immunodeficiency virus type 1 primary isolates and serves as a neutralization epitope J. Virol. 78, 2394-2404
22. Chakraborty, K., Durani, V., Miranda, E. R., Citron, M., Liang, X., Schleif, W., Joyce, J. G., and Varadarajan, R. (2006) Design of immunogens that present the crown of the HIV-1 V3 loop in a conformation competent to generate 447-52D-like antibodies Biochem. J. 399, 483-491
23. Varona-Santos, J. T., Vazquez-Padron, R. I., and Moreno-Fierros, L. (2006) Production of a short recombinant C4V3 HIV-1 immunogen that induces strong anti-HIV responses by systemic and mucosal routes without the need of adjuvants Viral Immunol. 19, 237-249
24. Chen, H., Xu, X., and Jones, I. M. (2007) Immunogenicity of the outer domain of a HIV-1 clade C gp120 Retrovirology 4, 33
25. Zhang, M. Y., Wang, Y., Mankowski, M. K., Ptak, R. G., and Dimitrov, D. S. (2009) Cross-reactive HIV-1-neutralizing activity of serum IgG from a rabbit immunized with gp41 fused to IgG1 Fc: possible role of the prolonged half-life of the immunogen Vaccine 27, 857-863
26. Guyre, P. M., Graziano, R. F., Goldstein, J., Wallace, P. K., Morganelli, P. M., Wardwell, K., and Howell, A. L. (1997) Increased potency of Fc-receptor-targeted antigens Cancer Immunol. Immunother. 45, 146-148
27. Haas, J., Park, E. C., and Seed, B. (1996) Codon usage limitation in the expression of HIV-1 envelope glycoprotein Curr. Biol. 6, 315-324
28. Fujita, K. and Takegawa, K. (2001) Chemoenzymatic synthesis of neoglycoproteins using transglycosylation with endo-beta- N - acetylglucosaminidase A Biochem. Biophys. Res. Commun. 282, 678-682
29. Lund, J., Takahashi, N., Popplewell, A., Goodall, M., Pound, J. D., Tyler, R., King, D. J., and Jefferis, R. (2000) Expression and characterization of truncated forms of humanized L243 IgG1. Architectural features can influence synthesis of its oligosaccharide chains and affect superoxide production triggered through human Fc-gamma receptor I Eur. J. Biochem. 267, 7246-7257
30. Trkola, A., Purtscher, M., Muster, T., Ballaun, C., Buchacher, A., Sullivan, N., Srinivasan, K., Sodroski, J., Moore, J. P., and Katinger, H. (1996) Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1 J. Virol. 70, 1100-1108 (Pubitemid 26029030)
31. Chen, H., Xu, X., Bishop, A., and Jones, I. M. (2005) Reintroduction of the 2G12 epitope in an HIV-1 clade C gp120 AIDS 19, 833-835
32. Chang, V. T., Crispin, M., Aricescu, A. R., Harvey, D. J., Nettleship, J. E., Fennelly, J. A., Yu, C., Boles, K. S., Evans, E. J., Stuart, D. I., Dwek, R. A., Jones, E. Y., Owens, R. J., and Davis, S. J. (2007) Glycoprotein structural genomics: solving the glycosylation problem Structure 15, 267-273
33. Scanlan, C. N., Ritchie, G. E., Baruah, K., Crispin, M., Harvey, D. J., Singer, B. B., Lucka, L., Wormald, M. R., Wentworth, P., Jr., Zitzmann, N., Rudd, P. M., Burton, D. R., and Dwek, R. A. (2007) Inhibition of mammalian glycan biosynthesis produces non-self antigens for a broadly neutralising, HIV-1 specific antibody J. Mol. Biol. 372, 16-22
34. Zhou, Q., Shankara, S., Roy, A., Qiu, H., Estes, S., McVie-Wylie, A., Culm-Merdek, K., Park, A., Pan, C., and Edmunds, T. (2008) Development of a simple and rapid method for producing non-fucosylated oligomannose containing antibodies with increased effector function Biotechnol. Bioeng. 99, 652-665
35. Stanfield, R. L., Gorny, M. K., Williams, C., Zolla-Pazner, S., and Wilson, I. A. (2004) Structural rationale for the broad neutralization of HIV-1 by human monoclonal antibody 447-52D Structure 12, 193-204